Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-002320
Filing Date
2014-03-13
Accepted
2014-03-13 16:05:08
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2218757z10-k.htm 10-K 1456092
2 EX-23.1 a2218757zex-23_1.htm EX-23.1 2867
3 EX-31.1 a2218757zex-31_1.htm EX-31.1 7310
4 EX-32.1 a2218757zex-32_1.htm EX-32.1 4097
11 G697431.JPG g697431.jpg GRAPHIC 50204
  Complete submission text file 0001047469-14-002320.txt   9550641

Data Files

Seq Description Document Type Size
5 EX-101.INS espr-20131231.xml EX-101.INS 1143412
6 EX-101.SCH espr-20131231.xsd EX-101.SCH 73897
7 EX-101.CAL espr-20131231_cal.xml EX-101.CAL 86793
8 EX-101.LAB espr-20131231_lab.xml EX-101.LAB 1112563
9 EX-101.PRE espr-20131231_pre.xml EX-101.PRE 682869
10 EX-101.DEF espr-20131231_def.xml EX-101.DEF 451619
Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 14691050
SIC: 2834 Pharmaceutical Preparations